Literature DB >> 25456903

Is central lymph node dissection necessary for parathyroid carcinoma?

Kun-Tai Hsu1, Rebecca S Sippel1, Herbert Chen1, David F Schneider2.   

Abstract

BACKGROUND: Parathyroid carcinoma is a rare cancer. Unlike other more common malignancies, the importance of lymph node (LN) status remains controversial. The purpose of this study was to determine the relative importance of LN metastases in disease-specific survival (DSS).
METHODS: A retrospective review of the Surveillance, Epidemiology, and End Result database was performed on parathyroid carcinoma cases diagnosed between 1988 and 2010.
RESULTS: We identified 405 parathyroid carcinoma patients. Among 114 patients with LNs examined at operation, only 12 (10.5%) had positive LNs. Sensitivity analysis found that a tumor size threshold of 3 cm best divided the cohort by DSS. Only tumors ≥ 3 cm and distant metastasis but not LN metastases were independent prognostic factors on multivariate analysis. When examining factors associated with LN status, only tumors ≥ 3 cm predicted LN metastasis. LN metastases were 7.5 times more likely in patients with tumors ≥ 3 cm than those with tumors <3 cm.
CONCLUSION: Tumors ≥ 3 cm were associated with LN metastases in parathyroid carcinoma, but positive LN status was not associated with DSS. Tumor size can potentially risk stratify patients by their risk of LN metastases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25456903      PMCID: PMC4254726          DOI: 10.1016/j.surg.2014.08.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  23 in total

1.  Parathyroid carcinoma: a diagnostic and therapeutic challenge.

Authors:  A R Shaha; J P Shah
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

Review 2.  Management of cancer of the parathyroid.

Authors:  Satish R Rao; Ashok R Shaha; Bhuvanesh Singh; Alessandra Rinaldo; Alfio Ferlito
Journal:  Acta Otolaryngol       Date:  2002-06       Impact factor: 1.494

Review 3.  Parathyroid carcinoma: a collective review.

Authors:  E C Holmes; D L Morton; A S Ketcham
Journal:  Ann Surg       Date:  1969-04       Impact factor: 12.969

4.  Parathyroid carcinoma. A study of 70 cases.

Authors:  A Schantz; B Castleman
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

5.  Parathyroid carcinoma: features and difficulties in diagnosis and management.

Authors:  B J Anderson; N A Samaan; R Vassilopoulou-Sellin; N G Ordonez; R C Hickey
Journal:  Surgery       Date:  1983-12       Impact factor: 3.982

Review 6.  Parathyroid carcinoma: clinical and pathologic features in 43 patients.

Authors:  A G Wynne; J van Heerden; J A Carney; L A Fitzpatrick
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

7.  Parathyroid carcinoma: is there a role for adjuvant radiation therapy?

Authors:  Nathan D Munson; Robert L Foote; Robert C Northcutt; Robert D Tiegs; Lorraine A Fitzpatrick; Clive S Grant; Jonathan A van Heerden; Geoffrey B Thompson; Ricardo V Lloyd
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

8.  Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes.

Authors:  Sam M Wiseman; Nestor R Rigual; Wesley L Hicks; Saurin R Popat; John M Lore; Wade G Douglas; Michael J Jacobson; Dongfeng Tan; Thom R Loree
Journal:  Ear Nose Throat J       Date:  2004-07       Impact factor: 1.697

9.  Parathyroid carcinoma: a 22-year experience.

Authors:  Naifa L Busaidy; Camilo Jimenez; Mouhammed Amir Habra; Pamela N Schultz; Adel K El-Naggar; Gary L Clayman; Joshua A Asper; Eduardo M Diaz; Douglas B Evans; Robert F Gagel; Adam Garden; Ana O Hoff; Jeffrey E Lee; William H Morrison; David I Rosenthal; Steven I Sherman; Erich M Sturgis; Steven G Waguespack; Randal S Weber; Kelly Wirfel; Rena Vassilopoulou-Sellin
Journal:  Head Neck       Date:  2004-08       Impact factor: 3.147

10.  Prognostic factors in parathyroid cancer: a review of 95 cases.

Authors:  K Sandelin; G Auer; L Bondeson; L Grimelius; L O Farnebo
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more
  8 in total

1.  Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma.

Authors:  Winifred M Lo; Meghan L Good; Naris Nilubol; Nancy D Perrier; Dhaval T Patel
Journal:  Ann Surg Oncol       Date:  2018-07-03       Impact factor: 5.344

2.  Mortality factors in recurrent parathyroid cancer: a pooled analysis.

Authors:  Wen-Hsuan Tsai; Yi-Hong Zeng; Chun-Chuan Lee; Ming-Chieh Tsai
Journal:  J Bone Miner Metab       Date:  2022-02-20       Impact factor: 2.626

3.  A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study.

Authors:  Mei Tao; Shuyan Luo; Xiaoming Wang; Meng Jia; Xiubo Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

4.  Spectrum of mitochondrial genomic variation in parathyroid neoplasms.

Authors:  Ya Hu; Xiang Zhang; Ou Wang; Xiaoping Xing; Ming Cui; Mengyi Wang; Chengli Song; Quan Liao
Journal:  Endocrine       Date:  2021-07-22       Impact factor: 3.633

5.  [Diagnostics and treatment of primary hyperparathyroidism].

Authors:  C Nies
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

6.  Prognostic Analysis for Patients With Parathyroid Carcinoma: A Population-Based Study.

Authors:  Bei Qian; Ying Qian; Longqing Hu; Shoupeng Zhang; Li Mei; Xincai Qu
Journal:  Front Neurosci       Date:  2022-02-18       Impact factor: 4.677

7.  Non-Linear Correlation Between Tumor Size and Survival Outcomes for Parathyroid Carcinoma: A SEER Population-Based Cohort Study.

Authors:  Kun Zhang; Anping Su; Xiaofei Wang; Wanjun Zhao; Linye He; Tao Wei; Zhihui Li; Jingqiang Zhu; Ya-Wen Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-01       Impact factor: 6.055

8.  Preoperative inflammatory markers for predicting parathyroid carcinoma.

Authors:  Keiko Ohkuwa; Kiminori Sugino; Ryohei Katoh; Mitsuji Nagahama; Wataru Kitagawa; Kenichi Matsuzu; Akifumi Suzuki; Chisato Tomoda; Kiyomi Hames; Junko Akaishi; Chie Masaki; Kana Yoshioka; Koichi Ito
Journal:  Endocr Connect       Date:  2022-07-14       Impact factor: 3.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.